Santhera Pharmaceuticals Holding (SPHDF)
OTHER OTC:SPHDF

Santhera Pharmaceuticals Holding (SPHDF) Cash flow

31 Followers

Santhera Pharmaceuticals Holding Cash Flow

SPHDF's free cash flow for Q2 2022 was CHF―. For the 2022 fiscal year, SPHDF's free cash flow was decreased by CHF6.17M and operating cash flow was CHF―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Operating Cash Flow
-CHF -37.36MCHF -43.51MCHF 2.60MCHF -37.87MCHF -39.63M
Investing Cash Flow
-CHF 69.00KCHF 1.56MCHF 2.79MCHF -5.91MCHF -22.24M
Financing Cash Flow
-CHF 46.02MCHF 23.15MCHF 4.13MCHF 20.64MCHF 57.11M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-CHF 21.21MCHF 12.41MCHF 31.36MCHF 21.97MCHF 45.20M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-CHF 20.35MCHF 901.00KCHF 8.96MCHF 25.80MCHF 9.41M
Issuance Of Debt
-CHF 35.79MCHF 24.56MCHF 4.73MCHF 0.00CHF 57.27M
Repayment Of Debt
-CHF -3.50MCHF 0.00CHF -4.73MCHF 0.00-
Free Cash Flow
-CHF -37.37MCHF -43.54MCHF 2.37MCHF -59.51MCHF -41.03M
Domestic Sales
------
Foreign Sales
------
Currency in CHF

Santhera Pharmaceuticals Holding Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis